Women’s Health Panel in Czechia

A focused, affordable preventive blood package for women aged 30 and over, giving a detailed snapshot of core health-status markers at a lower price point than the full comprehensive panel. It suits women who want a regular, accessible check of key metabolic and organ-function markers. Self-pay with no referral: book and pay online, attend a collection point, receive results electronically.

MEDEOR's Test plodnosti measures anti-Müllerian hormone (AMH), the key blood marker of ovarian reserve, for women in Přerov assessing fertility potential or planning ahead. It is a self-pay test analysed within the laboratory network, with no referral needed.

A self-pay Anti-Müllerian Hormone (AMH) blood test at the Zlín poliklinika collection point. AMH levels reflect the number of remaining eggs and give an estimate of ovarian reserve, helping women understand their current fertility window. Not covered by public insurance; offered as self-pay with no referral required and payment at the draw.

A blood test measuring anti-Müllerian hormone (AMH), a marker used to estimate ovarian reserve as part of female fertility assessment. Available as a walk-in self-pay test at MZ-Biochem.

A preventive blood package designed for women from their thirties, combining metabolic, iron, thyroid-relevant and general-health markers important to female health at this stage. Self-pay, no referral, results delivered electronically.

A women's hormone panel through LABSHOP assessing key reproductive and metabolic hormones relevant to cycle health, fertility, perimenopause and energy. Order online and collect at a SPADIA point in Prague.

IVF with egg donation at Royal Medical Prague uses anonymous Czech donors matched by phenotype (hair colour, eye colour, blood group) and aged 18–35, fully screened for genetic disease and STDs. The programme reports a 65% clinical pregnancy rate per transfer with donated eggs — substantially higher than IVF with a patient's own eggs for women over 40. No waiting lists apply, and treatment is available to women up to age 49. Royal Medical coordinates this with Dr. Jan Lacheta's fertility team, who have facilitated more than 10,000 successful IVF births. Genetic embryo screening (PGD/PGS) is available for optimal embryo selection. From €5,400 all-inclusive, this is a fraction of UK or US egg donation IVF pricing.